Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,078,445
-
Share change
-
-4,500,540
-
Total reported value
-
$42,233,869
-
Put/Call ratio
-
1157%
-
Price per share
-
$1.83
-
Number of holders
-
59
-
Value change
-
-$7,510,618
-
Number of buys
-
20
-
Number of sells
-
41
Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q2 2014
As of 30 Jun 2014,
AVEO PHARMACEUTICALS INC - COM (AVEO) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,078,445 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, Sarissa Capital Management LP, GREAT POINT PARTNERS LLC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Palo Alto Investors, LLC, D. E. Shaw & Co., Inc., GRANAHAN INVESTMENT MANAGEMENT INC/MA, and Deer VI & Co. LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.